Evidence map›Paper›PMID 28007024›Full record

ArticleGenome medicine2016

iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes.

Chengliang Dong, Yunfei Guo, Hui Yang, Zeyu He, Xiaoming Liu, Kai Wang

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Genome medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03192501 (Multicentre Perspective Non-interventional Study of Survival Benefits of iCAGES-guided Therapy in Contrast to Standard Therapy or IHC-guided Therapy for Advanced Cancers), which is not on this map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03192501 recruitingnot on this mapstarted 2017, after this paper: background citation

Multicentre Perspective Non-interventional Study of Survival Benefits of iCAGES-guided Therapy in Contrast to Standard Therapy or IHC-guided Therapy for Advanced Cancers

TypeobservationalSponsorSecond Affiliated Hospital of Guangzhou Medical UniversityRan2017 to 2039Enrolled250ConditionsLung Cancer, Gene Abnormality, Gene Product Sequence Variation, CancerArmsinhibitors, ADC drugs such as tarceva, capmatinib, padcev et al for A/C group.
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Identifying cancer driver genes in individual tumours.Computational and structural biotechnology journal · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Machine learning analysis of TCGA cancer data.PeerJ. Computer science · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chengliang DongZilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA, 90089, USA.
Yunfei GuoZilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA, 90089, USA.
Hui YangZilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA, 90089, USA.
Zeyu HeDepartment of Computer Science, New York University, New York, NY, 10012, USA.
Xiaoming LiuHuman Genetics Center, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Kai WangZilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA, 90089, USA. kw2701@cumc.columbia.edu.
University of Southern California · USNew York University · USThe University of Texas Health Science Center at Houston · US

Funding

Integrated variation detection annotation and analysis for high-throughout sequeR01HG006465 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WANG, KAI · 2012 to 2016
$1.8M
UNDERSTANDING THE FUNCTIONAL IMPACTS OF GENETIC VARIANTS IN MENTAL DISORDERSR01MH108728 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WANG, KAI · 2016 to 2018
$1.2M
NHGRI NIH HHS R01 HG006465NIMH NIH HHS R01 MH108728
6 · The paper itself

Abstract

Cancer results from the acquisition of somatic driver mutations. Several computational tools can predict driver genes from population-scale genomic data, but tools for analyzing personal cancer genomes are underdeveloped. Here we developed iCAGES, a novel statistical framework that infers driver variants by integrating contributions from coding, non-coding, and structural variants, identifies driver genes by combining genomic information and prior biological knowledge, then generates prioritized drug treatment. Analysis on The Cancer Genome Atlas (TCGA) data showed that iCAGES predicts whether patients respond to drug treatment (P = 0.006 by Fisher's exact test) and long-term survival (P = 0.003 from Cox regression). iCAGES is available at http://icages.wglab.org .

Indexed as

Databases, GeneticGenes, NeoplasmGenome, HumanSoftwareHumansNeoplasmsCancer genomicsMachine learningPrecision medicinePrecision oncologyTCGA

Identifiers

PMID28007024
PMCPMC5180414
OpenAlexW2565848986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.